Pipethanate ethobromide

Pipethanate ethobromide is an antimuscarinic with actions similar to those of atropine.


Adult Dose
Dose: 10 to 20 mg
Single Dose: 15 (15)
Frequency: As recommended.
Route: IM
Instructions: daily.
Neonatal
Paedriatic
Characteristics
.
Contraindications
Pipethanate ethobromide is contraindicated in conditions like Paralytic ileus,Close-angle glaucoma,Pyloric stenosis.
Effects
The severe or irreversible adverse effects of Pipethanate ethobromide, which give rise to further complications include Deaths.The signs and symptoms that are produced after the acute overdosage of Pipethanate ethobromide include Nausea, Vomiting, Confusion, Hallucinations, Ataxia, CNS stimulation, Incoordination, Rashes, Paranoid psychosis, Increased respiration rate, Excitement.
Indications
Pipethanate ethobromide is primarily indicated in conditions like Gastritis, Gastrointestinal spasm, Visceral spasms.
Interactions
No data regarding the interactions of Pipethanate ethobromide was found.
Interfrence
Risks
If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Warnings
Should be use with caution in patients with diarrhea, myasthenia gravis, fever, tachycardia, cardiac surgery, may cause mental confusion.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.